vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
16.40
-0.92 (-5.31%)
At close: Apr 1, 2025, 4:00 PM
17.50
+1.10 (6.70%)
After-hours: Apr 1, 2025, 4:18 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $52.31 million as of April 1, 2025. Its market cap has increased by 1.97% in one year.
Market Cap
52.31M
Enterprise Value
18.58M
1-Year Change
1.97%
Ranking
Category
Stock Price
$16.40
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $52.31M, a decrease of -85.36%. That is a compound annual growth rate of -18.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 55.20M | 25.45% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |